Skip to main content

Nifty slips below 200-DMA as breadth collapses — not a dip

Net new highs just turned negative, decliners beat advancers 2-to-1, and the Stage-2 cohort keeps shrinking.

Thursday, 23 July 20262 min readStage2Stocks Market Desk

Nifty 50
23,870
-0.5% on the day
Market
Neutral — Fading
1 session in this state
Breadth
41%
above 200-DMA · narrow
Adv / Dec
674 / 1,535
decliners ahead
52w highs / lows
110 / 123
net -13
Stage-2 share
33%
cohort narrowing

The tape is hollowing out, not pulling back inside strength. Today's -0.5% on Nifty 50 to 23,869.6 is the fifth losing or flat session in six, and the internals underneath are deteriorating faster than the index suggests — this is a broad decline, not a dip to buy. The regime has tipped to transition with a neutral-to-down near-term read, and the weight of evidence says risk is building.

Trajectory: the internals are getting worse, not stabilising

The slow structural gauge — the share of stocks above their 200-day average — has slid from 43.8% on 16 July to 41.4% today, a steady erosion that confirms distribution is not confined to a few names. The fast short-term gauge, stocks above their 20-day average, has collapsed from 43.5% to 31.1% over the same six sessions, and today's advance-decline of 1,535 decliners to 674 advancers is the second consecutive session of roughly 2-to-1 selling pressure. The clincher: net new 52-week highs just turned negative at -13, the first negative print in this sequence, meaning more stocks are making fresh lows than fresh highs. Over the last five days, 64 stocks degraded from Stage 2 to Stage 3 against only 36 moving the other way — a net loss of 28 from the advancing cohort — and the Stage-2 share has narrowed for five straight sessions to 33.1%.

Leadership: IT and Health Care holding, but the bench is thin

Information Technology was the only sector to close in the green today, up a marginal 0.2%, and it is where the Stage-2 cohort is expanding fastest over the last 20 days, alongside Health Care — the three-month leader at +15.8% — where RPG Life Sciences cleared the screen with a high setup score. Real Estate leads on the one-month table at +8.7% and its Stage-2 cohort is also widening, but one day's relative resilience in IT does not make a healthy market when decliners are running at more than double advancers. The setups the screen surfaces today are real — Kapston Services and Kabra Extrusion Technik in Industrials sit at the top — but in a tape where new lows are outpacing new highs and the advancing cohort is contracting, the historical follow-through rate on even clean setups deteriorates materially.

Leading Stage-2 setups
StockSectorSetup% 1D
Kabra Extrusion Technik LtdIndustrials9.4+2.9%
Kapston Services LtdIndustrials9.4-0.9%
Tirupati Forge LtdConsumer Discretionary9.2-5.0%
RPG Life Sciences LtdHealth Care9.0-3.4%
Bharat Seats LtdConsumer Discretionary9.0-1.6%
India Nippon Electricals LtdConsumer Discretionary9.0-0.5%
Filatex India LtdConsumer Discretionary9.0+0.4%
Muthoot Microfin LtdFinancials9.0-3.6%
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Information Technology+0.2%+4.2%-3.2%4231%
Consumer Discretionary-0.1%+2.6%+4.0%6835%
Health Care-0.5%+2.9%+15.8%7350%
Materials-0.7%+0.1%+0.5%6931%
Consumer Staples-0.7%+0.1%-3.2%5426%
Communication Services-0.8%+2.0%+9.1%6616%
Financials-0.8%-0.5%-3.3%6134%
Energy-1.0%-0.3%-3.5%5629%
Industrials-1.1%-3.1%+6.4%6937%
Utilities-1.3%-3.5%-1.2%6320%
Real Estate-1.4%+8.7%+10.1%5022%
Share of NSE stocks in Stage 2Jan 2026 – Jul 2026 · weekly
0%10%20%30%40%50%60%70%Jul 26Nifty 50Stocks in Stage 2Latest: 35%
The share of NSE stocks in Stage 2 over the six months to this wrap, with the Nifty's shape above it: the market underneath the day's numbers. Source: Stage2Stocks classification of every NSE stock with enough history, each week.
Try it on Stage2StocksHow to read this chart Lesson 3 of the course: why the Nifty isn't the market, and what the share of stocks in Stage 2 tells you.

Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

All market wraps →